3DM Inc. Launches PuraMatrix(TM) Synthetic Hydrogels at American Society for Cell Biology Conference
"PuraMatrix is one of the first commercial fruits of nanotechnology research, offering a completely characterized synthetic scaffold for cell- based assays and bioproduction of cells needing a 3-D extracellular matrix (ECM)," stated Dr. Alexander Rich, co-founder of 3DM and a pioneer in protein and nucleic acid chemistry. "Because of the purity and simplicity of design, PuraMatrix is likely to have many applications across drug discovery, biotechnology and human therapeutics."
BD Biosciences Discovery Labware is sponsoring an Exhibitor Showcase featuring PuraMatrix on Monday, December 15 at 7pm in (Room 300, Moscone Convention Center).
3DM co-founders Dr. Lisa Spirio and Dr. Carlos Semino will present a seminar describing the utility of the PuraMatrix hydrogel for promoting cell proliferation and differentiation. Scientific results recently highlighted in Nature (August 21, 2003), Differentiation (June, 2003), and Nature Biotechnology (October, 2003) will be presented. The PuraMatrix hydrogel will complement Becton Dickinson's existing product lines used for cell culture applications for life science, drug discovery, and tissue engineering research.
Dr. Lisa Spirio, Director of Research & Development for 3DM, emphasized "Major publications and grant-making institutions have touted the benefits of 3-D cell culture this year. 2003 may prove to be a tipping point in the realization that 3D culture, especially synthetic ECM analogs, allows more accurate study of cell biology in vitro. The new US$40 million National Cancer Institute program on the cellular micro-environment places a major emphasis on research and adoption of 3-D culture techniques, validating the field of 3-dimensional cell culture and driving its adoption beyond cancer research and tissue engineering."